Pharma industry’s SG&A expenses accounting for 30.5% of total sales

It was observed the pharmaceutical companies’ SG&A(selling, general and administrative) expenses, which reached about 30% of their sales, have been a factor that blocks the way from increasing profitability.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the 2016 SG&A expenses spent by 61 listed pharmaceutical companies, 74 unlisted pharmaceutical companies and 32 foreign ...